Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone

M. A. Dimopoulos; K. C. Weisel; K. W. Song; M. Delforge; L. Karlin; H. Goldschmidt; P. Moreau; A. Banos; A. Oriol; L. Garderet; M. Cavo; V. Ivanova; A. Alegre; J. Martinez-Lopez; C. Chen; A. Spencer; S. Knop; N. J. Bahlis; C. Renner; X. Yu; K. Hong; L. Sternas; C. Jacques; M. H. Zaki; J. F. San Miguel

doi:10.3324/haematol.2014.117077

Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone

Haematologica ◽

10.3324/haematol.2014.117077 ◽

2015 ◽

Vol 100 (10) ◽

pp. 1327-1333 ◽

Cited By ~ 49

Author(s):

M. A. Dimopoulos ◽

K. C. Weisel ◽

K. W. Song ◽

M. Delforge ◽

L. Karlin ◽

...

Keyword(s):

Multiple Myeloma ◽

Low Dose ◽

Term Survival ◽

Long Term Survival ◽

Refractory Multiple Myeloma

Download Full-text

P-187: Expert elicitation of long-term survival (LTS) for patients (pts) with relapsed/refractory multiple myeloma (RRMM) treated with idecabtagene vicleucel (ide-cel, bb2121) in the KarMMa phase 2 trial

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/s2152-2650(21)02314-4 ◽

2021 ◽

Vol 21 ◽

pp. S139-S140

Author(s):

Dieter Ayers ◽

Shannon Cope ◽

Devender S. Dhanda ◽

Kevin Towle ◽

Ali Mojebi ◽

...

Keyword(s):

Multiple Myeloma ◽

Expert Elicitation ◽

Phase 2 ◽

Term Survival ◽

Long Term Survival ◽

Refractory Multiple Myeloma ◽

Phase 2 Trial

Download Full-text

Melflufen plus dexamethasone in relapsed/refractory multiple myeloma: long‐term survival follow‐up from the Phase II study O‐12‐M1

British Journal of Haematology ◽

10.1111/bjh.17302 ◽

2021 ◽

Author(s):

Sara Bringhen ◽

Peter M. Voorhees ◽

Torben Plesner ◽

Ulf‐Henrik Mellqvist ◽

Brandi Reeves ◽

...

Keyword(s):

Multiple Myeloma ◽

Phase Ii ◽

Phase Ii Study ◽

Term Survival ◽

Long Term Survival ◽

Refractory Multiple Myeloma

Download Full-text

Long term survival in multiple myeloma: a single institution experience in underprivileged circumstances

Leukemia & Lymphoma ◽

10.1080/10428194.2021.2012665 ◽

2021 ◽

pp. 1-6

Author(s):

Lorena Bojalil-Alvarez ◽

Morie A. Gertz ◽

Elizabeth Garcia-Villaseñor ◽

José Antonio Fernández-Gutiérrez ◽

Oscar Alfonso Reyes-Cisneros ◽

...

Keyword(s):

Multiple Myeloma ◽

Single Institution ◽

Term Survival ◽

Long Term Survival

Download Full-text

Predicting Long-term Survival in Multiple Myeloma Patients Following Autotransplants

Leukemia & Lymphoma ◽

10.1080/1042819031000067567 ◽

2003 ◽

Vol 44 (5) ◽

pp. 749-758 ◽

Cited By ~ 6

Author(s):

Athanasios B.-T. Fassas ◽

Frits Van Rhee ◽

Guido Tricot

Keyword(s):

Multiple Myeloma ◽

Term Survival ◽

Long Term Survival

Download Full-text

Acute xenograft rejection, late xenograft rejection and long term survival xenografts in the hamster-to-rat heart transplantation model: histological characterisation under low-dose of FK506

Apmis ◽

10.1034/j.1600-0463.2002.1101008.x ◽

2002 ◽

Vol 110 (10) ◽

pp. 737-745 ◽

Cited By ~ 4

Author(s):

MIREIA MORELL GINESTA ◽

YOLANDA RIBAS ◽

DAVID G. MOLLEVI ◽

AUGUST VIDAL ◽

RAFAEL MANEZ ◽

...

Keyword(s):

Heart Transplantation ◽

Rat Heart ◽

Low Dose ◽

Term Survival ◽

Long Term Survival ◽

Xenograft Rejection ◽

Transplantation Model

Download Full-text

Long-term survival in multiple myeloma

Archives of Internal Medicine ◽

10.1001/archinte.146.8.1637a ◽

1986 ◽

Vol 146 (8) ◽

pp. 1637a-1638 ◽

Cited By ~ 1

Author(s):

J. Blade

Keyword(s):

Multiple Myeloma ◽

Term Survival ◽

Long Term Survival

Download Full-text

Intermittent Low-Dose IFN Gamma Treatment for Metastatic Renal Cell Carcinoma: Analysis of Factors Predicting Clinical Response and Long-Term Survival

Oncology Research and Treatment ◽

10.1159/000218614 ◽

1995 ◽

Vol 18 (4) ◽

pp. 339-345 ◽

Cited By ~ 1

Author(s):

W.E. Aulitzky ◽

W. Aulitzky ◽

J. Ellerhorst ◽

C. Logothetis ◽

A. Gomahr ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Clinical Response ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Low Dose ◽

Term Survival ◽

Ifn Gamma ◽

Long Term Survival

Download Full-text

Long-term survival and polyclonal immunoglobulin reconstitution after allogeneic stem cell transplantation in multiple myeloma

Annals of Hematology ◽

10.1007/s00277-020-04068-5 ◽

2020 ◽

Vol 99 (8) ◽

pp. 1907-1915

Author(s):

Christine Eisfeld ◽

Eva Eßeling ◽

Ramona Wullenkord ◽

Cyrus Khandanpour ◽

Julia Reusch ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Allogeneic Stem Cell Transplantation ◽

Term Survival ◽

Long Term Survival ◽

Polyclonal Immunoglobulin

Download Full-text

Long-term survival estimates for imatinib versus interferon-? plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia

Cancer ◽

10.1002/cncr.20674 ◽

2004 ◽

Vol 101 (11) ◽

pp. 2584-2592 ◽

Cited By ~ 28

Author(s):

Kevin J. Anstrom ◽

Shelby D. Reed ◽

Andrew S. Allen ◽

G. Alastair Glendenning ◽

Kevin A. Schulman

Keyword(s):

Chronic Myeloid Leukemia ◽

Myeloid Leukemia ◽

Low Dose ◽

Chronic Phase ◽

Newly Diagnosed ◽

Term Survival ◽

Long Term Survival ◽

Low Dose Cytarabine

Download Full-text

Long-term survival with cyclophosphamide, bortezomib and dexamethasone induction therapy in patients with newly diagnosed multiple myeloma

British Journal of Haematology ◽

10.1111/bjh.13004 ◽

2014 ◽

Vol 167 (4) ◽

pp. 563-565 ◽

Cited By ~ 22

Author(s):

Craig B. Reeder ◽

Donna E. Reece ◽

Vishal Kukreti ◽

Joseph R. Mikhael ◽

Christine Chen ◽

...

Keyword(s):

Multiple Myeloma ◽

Induction Therapy ◽

Newly Diagnosed ◽

Term Survival ◽

Long Term Survival

Download Full-text